131I-labeled peptides as caspase substrates for apoptosis imaging

Journal of Nuclear Medicine

Volumn 46, Issue 6, 2005, Pages 1066-1074

  Bauer, Claudia ^a   Bauder Wuest, Ulrike ^a   Mier, Walter ^b   Haberkorn, Uwe ^b   Eisenhut, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; Caspase substrates; Jurkat cells; Radioiodine; Tat

Indexed keywords

AMINO ACID; ASPARTYLGLUTAMYLVALYLASPARTYLGLYCINE; CASPASE; CASPASE 3; IODINE 131; TECHNETIUM 99M; TECHNETIUM HYDRAZINONICOTINAMIDE ANNEXIN V TECHNETIUM 99 M; UNCLASSIFIED DRUG; CASP3 PROTEIN, HUMAN; OLIGOPEPTIDE; RADIOACTIVE IODINE;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; CHEMISTRY; ENZYME SPECIFICITY; LEUKEMIA CELL LINE; MASS SPECTROMETRY; METABOLISM; SCINTISCANNING; STRUCTURE ACTIVITY RELATION;

APOPTOSIS; CASPASE 3; CASPASES; HUMANS; IODINE RADIOISOTOPES; JURKAT CELLS; OLIGOPEPTIDES; RADIONUCLIDE IMAGING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 23044458593     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zomig M, Baum W, Hueber A-O, Evan G. Programmed cell death and senescence. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, eds. The Molecular Basis of Cancer. 2nd ed. Philadelphia, PA: WB Saunders; 2001:19-40.
2. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanism in stroke. Cell Tissue Res. 2000;301:173-187.
3. Kabelitz D. Apoptosis, graft rejection, and transplantation tolerance. Transplantation. 1998;65:869-875.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
5. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998;95:6349-6354.
6. Emoto K, Toyama-Sonmachi N, Karasuyama H, et al. Exposure of phophatidylethanolamine on the surface of apoptotic cells. Exp Cell Res 1997;232:430-434.
7. Wood BL, Gibson DF, Tait JF. Increased erythrocytephophatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
8. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000;356:209-212.
9. 99mTc-annexin V. J Nucl Med. 2001;42:382-387.
10. 99mTc-BTAP-annexin-V in humans. Eur J Nucl Med 2001;28:1373-1378.
11. 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med. 2003;44:947-952.
12. Ohtsuki K, Akashi K, Aoka Y, et al. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis. Eur J Nucl Med 1999;26:1251-1258.
13. Nicolson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 1997;22:299-306.
14. Cohen GM. Caspases: the executioners of apoptosis. J Biochem 1997;326:1-16.
15. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;282:1312-1316.
16. Villa P, Kaufmann SH, Earnshaw WC. Caspase and caspase inhibitors. Trends Biochem Sci. 1997;22:388-393.
17. Hirsch T, Marchetti P, Susin SA, et al. The apoptosis-necrosis paradox: apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene. 1997;15:1573-1581.
18. Lazebnik YA, Kaufmann SH, Desnoyers S, et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994;371:346-347.
19. Haberkorn U, Kinscherf R, Krammer PH, et al. Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val- Ala-DL-Asp(o-methyl)- fluoromethylketone. Nucl Med Biol. 2001;28:793-798.
20. Eisenhut M, Mier W. Radioiodination chemistry and radioiodinated compounds. In: Vertes A, Nagy S, Klencsar Z, eds. Handbook of Nuclear Chemistry. Amsterdam, The Netherlands: Kluwer Academic Publishers; 2003:257-278.
21. Bosch I, Crankshaw CL, Piwnica-Worms D, Croop JM. Characterization of functional assays of multidrug resistance P-glycoprotein transport activity. Leukemia. 1997;11:1131-1137.
22. Hug H, Los M, Hirt W, Debatin KM. Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells. Biochemistry. 1999;38:13906-13911.
23. Eamshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, substrates, and function during apoptosis. Annu Rev Biochem. 1999;68:384-424.
24. Scheller A, Oelke J, Wiesner E, et al. Structural requirements for cellular uptake of alpha-helicial amphiphatic peptides. J Pept Sci. 1999;5:185-194.
25. Pooga M, Hällbrink M, Zorko M, Langel Ü. Cell penetration by transportan. FASEB J. 1998;12:67-77.
26. Wender PA, Mitchell DJ, Pattabiraman K, et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA. 2000;97:13003-13008.
27. Prochiantz A. Getting hydophilic compounds into cells: lesson from home opeptides. Curr Opin Neurobiol. 1996;6:629-634.
28. Hällbrink M, Florén A, Elmquist A, et al. Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta. 2001;1515:101-109.
29. Lindgren M, Hällbrink M, Prochiantz A, Langel U. Cell-penetrating peptides. Trends Pharmacol Sci. 2000;2:99-103.
30. Gammon ST, Villalobos VM, Prior JL, et al. Quantitative analysis of permeation peptide complexes labeled with technetium-99-m: chiral and sequence-specific effects on net cell uptake. Bioconjug Chem. 2003;14:368-376.